Grützmann R, Foerder M, Alldinger I, Staub E,
Brümmendorf T, Röpke S, Li X, Kristiansen G, Jesnowski
R, Sipos B, Löhr M, Lüttges J, Ockert D, Klöppel
G, Saeger HD, Pilarsky C: Gene expression profiles of
microdissected pancreatic ductal adenocarcinoma. Virchows Arch 443: 508-517, 2003.
Schreiner B, Baur DM, Fingerle AA, Zechner U, Greten FR,
Adler G, Sipos B, Klöppel G, Hameister H, Schmid
RM: Pattern of secondary genomic changes in pancreatic
tumors of Tgf-alpha / Trp53+/- transgenic mice. Genes
Chromos Cancer 38: 240-248, 2003.
Sipos B, Möser S, Kalthoff H, Török V, Löhr M,
Klöppel G: A comprehensive characterization of
pancreatic ductal carcinoma cell lines: towards the
establishment of an in vitro research platform. Virchows Arch 442: 444-452, 2003.
Trauzold A, Schmiedel S, Sipos B, Wermann H,
Westphal S, Röder C, Klapper W, Arlt A, Lehnert L,
Ungefroren H, Johannes F-J, Kalthoff H: PKCmu prevents
CD95-mediated apoptosis and enhances proliferation in
pancreatic tumour cells. Oncogene 22:
8939-8947, 2003.
Bando H, Brokelmann M, Toi M, Alitalo K, Sleeman JP, Sipos B, Grone HJ, Weich HA: Immunodetection and
quantification of vascular endothelial growth factor
receptor-3 in human malignant tumor tissues. Int J
Cancer 111: 184-191, 2004.
Grützmann R, Pilarsky C, Ammerpohl O, Lüttges J, Böhme
A, Sipos B, Foerder M, Alldinger I, Jahnke B,
Schackert HK, Kalthoff H, Kremer B, Klöppel G, Saeger
HD: Gene expression profiling of microdissected
pancreatic ductal carcinomas using hogh-density DNA
microarrays. Neoplasia 6: 611-622, 2004.
Müerköster S, Wegehenkel K, Arlt A, Witt M, Sipos B,
Kruse M-L, Sebens T, Klöppel G, Kalthoff H, Fölsch UR,
Schäfer H: Tumor stroma interactions induce
chemoresistance in pancreatic ductal carcinoma cells
involving increased secretion and paracrine effects of
nitric oxide and interleukin-1b. Cancer Res 64:
1331-1337, 2004.
Sipos B, Klapper W, Kruse M-L, Kalthoff H,
Kerjaschki D, Klöppel G: Expression of lymphangiogenic
factors and evidence of intratumoral lymphangiogenesis
in pancreatic endocrine tumors. Am J Pathol 165: 1187-1197, 2004.
Sipos B, Hahn D, Carceller A, Piulats J,
Hedderich J, Kalthoff H, Goodman SL, Kosmahl M, Klöppel
G: Immunohistochemical screening for b6-integrin subunit
expression in adenocarcinomas using a novel monoclonal
antibody reveals strong up-regulation in pancreatic
ductal adenocarcinomas in vivo and in vitro. Histopathology 45: 226-236, 2004.
Weich HA, Bando H, Brokelmann M, Baumann P, Toi M,
Barleon B, Alitalo K, Sipos B, Sleeman J:
Quantification of vascular endothelial growth factor-C
(VEGF-C) by a novel ELISA. J Immunol Methods 285: 145-155, 2004.
Müerköster S, Arlt A, Sipos B, Witt M, Großman M,
Klöppel G, Kalthoff H, Fölsch UR, Schäfer H: Increased
expression of the E3-ubiquitin ligase receptor subunit
bTRCP1 relates to constitutive nuclear factor-kB
activation and chemoresistance in pancreatic carcinoma
cells. Cancer Res 65: 1316-1324, 2005.
Trauzold A, Röder C, Sipos B, Karsten K, Arlt A,
Jiang P, Martin-Subero JI, Siegmund D, Müerköster S,
Raluy LP, Siebert R, Wajant H, Kalthoff H: CD95 and
TRAF2 promote invasiveness of pancreatic cancer cells. FASEB J 19: 620-622, 2005.
Sipos B, Kojima M, Tiemann K, Klapper W, Kruse
M-L, Kalthoff H, Schniewind B, Tepel J, Weich H,
Kerjaschki D, Klöppel G: Lymphatic spread of ductal
pancreatic adenocarcinoma is independent of
lymphangiogenesis. J Pathol 207: 301-312,
2005.
Tepel J, Dagvadorj O, Kapischke M, Sipos B, Leins
A, Kremer B , Kalthoff H: Significant growth inhibition
of orthotopic pancreatic ductal adenocarcinoma by CpG
oligonucleotides in immunodeficient mice. Int J
Colorectal Dis 21: 365-372, 2005.
Book chapter
Sipos B, Real FX, Moore P, Kalthoff H, Scarpa A,
Klöppel G: Genetic and cellular characteristics of
pancreatic carcinoma cell lines. In: Gress TM,
Neoptolemos JP, Lemoine NR, Real FX (eds.) Exocrine
pancreas cancer. The European Pancreatic Cancer-Research
Cooperative (EPC-RC). Felsenstein CCCP, Hannover, pp
120-135, 2005 |
Bence.Sipos(at)med.uni-tuebingen.de